WO2003000332A1 - Catheter a ballonnet - Google Patents
Catheter a ballonnet Download PDFInfo
- Publication number
- WO2003000332A1 WO2003000332A1 PCT/EP2002/006970 EP0206970W WO03000332A1 WO 2003000332 A1 WO2003000332 A1 WO 2003000332A1 EP 0206970 W EP0206970 W EP 0206970W WO 03000332 A1 WO03000332 A1 WO 03000332A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balloon
- stent
- catheter
- balloon catheter
- distal end
- Prior art date
Links
- 239000000463 material Substances 0.000 claims description 11
- 238000005304 joining Methods 0.000 claims description 2
- 210000001367 artery Anatomy 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 230000003902 lesion Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
Definitions
- This invention relates to balloon catheters and particularly, but not exclusively, to balloon catheters incorporating stents.
- Balloon catheters are used in the treatment of various anatomical ducts in the body, such as blood vessels, the urinary ducts, or digestive ducts. A particular application is in the treatment of blood vessels exhibiting stenosis.
- the conventional balloon catheter comprises a catheter delivery tube on the distal end of which is mounted a balloon of flexible material.
- the balloon is moved along blood vessels within the body to the site of the lesion and, when correctly positioned, is inflated, usually by means of fluid pressure supplied along the hollow interior of the catheter delivery tube.
- the balloon inflates it expands against the vessel wall and thus applies outwards pressure to the wall tending to enlarge the vessel's lumen to remove or reduce the effect of a partly blocked vessel.
- the pressure is released, and the balloon deflates and is removed, leaving the vessel in its enlarged state.
- a stent may optionally be carried by the balloon and left in place when the balloon is removed in order to act as a reinforcement for the vessel wall, thus maintaining the enlarged state of the lumen.
- stent available and their construction and deployment are both well known.
- a particular problem with balloon catheters arises as a result of overstretching during inflation of the balloon which not only damages the balloon, rendering it difficult to deflate and fold properly for removal, but more significantly can cause damage to the vessel being treated. This is a particular problem when a stent is fitted, and gives rise to a phenomena known as "dog-boning".
- Figures 1 and 2 of the accompanying drawings show diagrammatically and not to scale a balloon mounted with a stent both before inflation ( Figure 1 ) and after inflation ( Figure 2).
- Figure 1 there is illustrated the wall 1 of an artery to be treated, the artery exhibiting a lesion 2 such as a stenosis or cholesterol plaque.
- a lesion 2 such as a stenosis or cholesterol plaque.
- the balloon catheter comprises a catheter delivery tube (not shown) on which is mounted, at its distal end, a balloon 4. Crimped over the balloon 4 is a stent 5.
- Radio-opaque marker bands normally attached to the catheter delivery tube, may be used, in conjunction with external radiographic apparatus, to enable the surgeon to precisely position the balloon at the correct location.
- the balloon is inflated via the catheter delivery tube.
- the balloon 4 and the stent 5 expand together in a radially outwards direction towards the interior of the artery wall.
- two events occur, namely the balloon increases in length along its longitudinal axis while, at the same time, the stent decreases in length.
- the dog-boning effect may be reduced or even eliminated by careful sizing of the stent in relation to the balloon, and by precise positioning of the stent on the balloon.
- careful sizing of the stent in relation to the balloon and by precise positioning of the stent on the balloon.
- the balloon and marker bands there is a risk of approximately 2-4 mm inaccuracy when placing the stent in relation to the balloon.
- the present invention seeks to reduce or eliminate the dog-boning effect. This is achieved by making one, or preferably both, ends of the balloon concave whereby to better resist the outward force created by the inflation pressure applied to the balloon during its expansion.
- a balloon catheter comprising an expandable balloon made of flexible material, and mounted on the distal end of a catheter delivery tube, said balloon being made up of proximal and distal end sections which join to the catheter, a central section having a generally cylindrical shape, and proximal and distal intermediate sections joining the central section to the proximal and distal end sections respectively, the balloon catheter being characterised in that, in its unexpanded state, the central section has a greater diameter than the end sections and at least one of the intermediate sections has a concave profile.
- both intermediate sections Preferably both intermediate sections have a concave profile.
- an expandable stent is mounted over the central section of the stent.
- the benefits of the invention will be felt in a balloon without a stent.
- At least one of the intermediate sections has a continuous curved concave profile from the smaller diameter of the respective end sections to the larger diameter of the central section. It is possible that a small diameter step may be present at the smaller or larger diameter end of the intermediate section, but it will be understood that the majority of the step between the smaller and larger diameters is effected by the concave profile; otherwise the desirable advantages of the invention will not be realised.
- the balloon is designed so that, as inflation pressure is applied, it is the central section which expands, whilst the end sections remain attached to the catheter.
- the intermediate sections which act as the interface between those parts of the balloon which expand, and those which do not.
- the intermediate sections need to be flexible and since, even if a stent is fitted, they are not restrained on the exterior, there is always a danger that they will expand excessively on inflation of the balloon.
- the use of intermediate sections substantially of concave profile enables the inflation pressure to be resisted to a greater extent.
- a stiff ring made for example of polymer material such as Pebax, is fitted over the catheter delivery tube at the distal end of the balloon.
- the ring is positioned within the balloon beyond the distal end of the stent and thus causes a local enlargement in the unexpanded balloon against which the stent may abut, thus limiting movement of the stent in the distal direction.
- the ring has an external diameter, when fitted, which is slightly less than that of the unexpanded stent so as to reduce the radial dimension of the step which is formed at the end of the stent.
- a similar ring can alternatively be fitted at the proximal end of the stent, or rings can be fitted at both ends of the stent, this latter arrangement thus having the effect of trapping the stent between the two local enlargements so formed.
- the distal and proximal rings may be positioned so as to prevent longitudinal movement of the stent altogether, or a limited degree of movement may be permitted.
- the distal ring (and proximal ring if fitted) may be positioned at least partially over the marker bands which happen also to be positioned just beyond the ends of the stent.
- Figure 1 is a diagrammatic view of a balloon catheter with mounted stent positioned within an artery, and shown in its unexpanded state prior to inflation;
- Figure 2 is a view similar to Figure 1 , but showing the arrangement after inflation;
- FIGS 3 and 4 are diagrammatic views of two alternative embodiments of balloon catheter according to the invention, shown in their unexpanded state, prior to inflation;
- Figure 5 is a lengthwise cross sectional view of the balloon of a balloon catheter according to an embodiment of the invention.
- Figures 6 and 7 are views similar to Figures 1 and 2 respectively, but showing the balloon catheter of Figure 4;
- Figure 8 is a lateral sectional view showing how the balloon of Figure 5 is folded
- Figure 9 is a diagrammatic sketch showing the cross section of a conventional balloon, with stent, prior to inflation;
- Figure 10 is a view similar to Figure 9, but showing a ring attached about the catheter delivery tube;
- Figure 11 shows the arrangement of Figure 10, after inflation
- Figures 12 and 13 are views similar to Figures 10 and 11 respectively, but showing a ring positioned at both ends of the stent.
- Figures 3 and 4 there are shown the two basic embodiments of the invention: one which is concave at one end, and one which is concave at both ends.
- Figures 3 and 4 are diagrammatic, and are not drawn to scale.
- the balloon 4 essentially comprises five sections joined together along a longitudinal axis 10. The five sections are, from left to right:-
- the sections are preferably joined together as an integral whole, and are made from flexible plastics material such as polyamide PA.
- the intermediate sections 12,14 act to join the respective end sections 11 ,15 to the central section 13.
- the end sections 11 ,15 are joined to the exterior of a catheter delivery tube 3 which passes through the balloon coaxial with its longitudinal axis 10. Apertures in the wall of the tube as it passes through the balloon allow for inflation of the balloon. Formed on the tube 3 are proximal and distal marker bands 16,17 respectively which are positioned beyond the ends of the stent (not shown).
- the marker bands are formed as small metal bands mounted on the catheter delivery tube.
- the bands are radio-opaque so that, with the aid of suitable radiographic apparatus (not shown), the surgeon is able to effectively see the catheter on a display screen, but also make sure that the stent, usually also of metal, can be positioned accurately between the bands.
- the proximal intermediate section 12 is concave over the whole of its length from the reduced diameter of proximal end, section 11 to the larger diameter of central section 13.
- the distal intermediate section 14 is largely straight, sloping at an angle to the longitudinal axis from the reduced diameter of distal end section 15 to the larger diameter of central section 13.
- both intermediate sections 12 and 14 have a concave shape similar to that of section 12 of Figure 3.
- a more accurate drawing of the balloon only of Figure 4 is provided in Figure 5 in which typically the total length L1 of the two intermediate sections 12,14 and the central section 13 lies in the range 10 mm to 40 mm while the length L2 of each of the intermediate sections 12,14 lies in the range 2 mm to 5 mm.
- Figure 5 shows the shape of the balloon as it emerges from the mould.
- the mould used is an external mould, with pressure applied from the interior to blow the balloon material outwards so that it takes up the shape of the mould - in other words, the exterior shape of the balloon corresponds to the interior shape of the mould.
- Figure 5 shows the balloon unfolded and in its unexpanded state prior to inflation.
- the central section 10 is substantially cylindrical in shape and the intermediate sections are concave in shape.
- a stent (not shown) may be fitted over the central section 10.
- Figure 6 shows diagrammatically the balloon of Figure 5 positioned within an artery 1 to be treated, and prior to inflation.
- Figure 7 shows the arrangement after inflation - it will be seen that the inflation pressure has caused the naturally concave intermediate sections 12,14 to become convex, but they have not expanded outwardly in the gross way illustrated in Figure 2. Obviously, if extreme inflation pressure were applied, then, dog-boning would occur even with the balloon of Figure 5, but it has been found that, with the pressures normally necessary to expand the balloon, and any stent mounted thereon, the dog-boning effect is substantially reduced or eliminated by the use of concave intermediate sections.
- Figure 5 shows the balloon in its unstressed or natural state, prior to the application of inflation pressure.
- the diameter of the balloon is at its minimum.
- the balloon is folded to a smaller diameter and the use of concave ends has been found to assist the folding possibilities.
- folding techniques one of which is shown in Figure 8 in which the material of the central section of the balloon is folded to form three longitudinally extending "arms" 20 which are circumferentially evenly spaced (i.e. 120° apart). After being folded, the arms are themselves folded around the catheter delivery tube 3 in the clockwise or anticlockwise direction, as illustrated by the clockwise arrows in Figure 8.
- the balloon can be folded so that its final diameter is substantially constant around the circumference, at around 6 material thicknesses above the diameter of the catheter delivery tube 3. If a stent is fitted, this may be crimped about the folded balloon and carried to the lesion site with the balloon.
- the inflation of the balloon proceeds in two stages: a first stage in which the balloon unfolds from the folded position shown in Figure 8 to the unstressed position shown in Figure 5, and a second stage in which the balloon material stretches to further expand the diameter of the central section, and any stent mounted thereon.
- Figure 9 shows a conventional balloon catheter 4 prior to inflation, on which is crimped a stent 5.
- a ring 30 of stiff polymer material such as Pebax, is mounted on the catheter delivery tube 3, partly over marker band 17 at the distal end of the balloon, and abutting the distal end of the stent 5. It will be noted that the ring 30 is situated within the balloon 4 and the balloon material thus passes over the outer circumference of the ring. The ring 30 will be seen to reduce the relatively large step 6 at the distal end of the stent to two smaller steps, thus improving the profile presented by the combination of the balloon and the mounted stent.
- the outer diameter of the ring 30 is sufficiently large that the outer diameter of the balloon, as it passes over the ring 30, approximately matches that of the stent so that the stent in fact does not present an edge at all.
- the outer diameter of ring 30 is such that the outer diameter of the balloon as it passes over the ring is greater than that of the stent. The presence of the ring 30 prevents the stent from coming into contact with the lesion 2 during angioplasty.
- a similar ring 31 of polymer material may also be added at the proximal end of the stent.
- the ring 31 is positioned partly over the proximal marker band 16.
- the rings 30,31 are shown positioned over the respective marker bands 17,16, this is not essential; it is just that the normal positioning of marker bands is immediately adjacent the ends of the stent, and this is the position which the rings 30,31 also best occupy. Since the rings 30,31 are of plastics material, they do not affect the ability of the marker bands 16,17 to be "seen" by the radiographic equipment.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02740750A EP1404404A1 (fr) | 2001-06-25 | 2002-06-24 | Catheter a ballonnet |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0115529.0 | 2001-06-25 | ||
GB0115529A GB0115529D0 (en) | 2001-06-25 | 2001-06-25 | Balloon catheter |
EP01305510 | 2001-06-26 | ||
EP01305510.8 | 2001-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003000332A1 true WO2003000332A1 (fr) | 2003-01-03 |
Family
ID=26077148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/006970 WO2003000332A1 (fr) | 2001-06-25 | 2002-06-24 | Catheter a ballonnet |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1404404A1 (fr) |
WO (1) | WO2003000332A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130245552A1 (en) * | 2009-10-19 | 2013-09-19 | Vatrix Medical Inc. | Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections |
CN105536123A (zh) * | 2016-02-18 | 2016-05-04 | 仇汉诚 | 一种球囊导管 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0274846A1 (fr) * | 1986-12-09 | 1988-07-20 | Boston Scientific Corporation | Appareil pour le traitement d'hypertrophie de la glande prostatique |
WO1997021400A1 (fr) * | 1995-12-11 | 1997-06-19 | Guerin Yves Francois | Dispositif d'implantation d'une endoprothese vasculaire |
US5669932A (en) * | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
WO2000056248A1 (fr) * | 1999-03-22 | 2000-09-28 | Scimed Life Systems, Inc. | Manchon lubrifie pour la mise en place de stents |
WO2000057945A2 (fr) * | 1999-03-31 | 2000-10-05 | Advanced Cardiovascular Systems, Inc. | Systeme de catheter a ballonnet et de catheter de deploiement d'endoprothese |
WO2001012255A1 (fr) * | 1999-08-12 | 2001-02-22 | Wilson-Cook Medical Inc. | Ballonnet de dilatation a diametres multiples |
-
2002
- 2002-06-24 EP EP02740750A patent/EP1404404A1/fr not_active Withdrawn
- 2002-06-24 WO PCT/EP2002/006970 patent/WO2003000332A1/fr not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0274846A1 (fr) * | 1986-12-09 | 1988-07-20 | Boston Scientific Corporation | Appareil pour le traitement d'hypertrophie de la glande prostatique |
WO1997021400A1 (fr) * | 1995-12-11 | 1997-06-19 | Guerin Yves Francois | Dispositif d'implantation d'une endoprothese vasculaire |
US5669932A (en) * | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
WO2000056248A1 (fr) * | 1999-03-22 | 2000-09-28 | Scimed Life Systems, Inc. | Manchon lubrifie pour la mise en place de stents |
WO2000057945A2 (fr) * | 1999-03-31 | 2000-10-05 | Advanced Cardiovascular Systems, Inc. | Systeme de catheter a ballonnet et de catheter de deploiement d'endoprothese |
WO2001012255A1 (fr) * | 1999-08-12 | 2001-02-22 | Wilson-Cook Medical Inc. | Ballonnet de dilatation a diametres multiples |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130245552A1 (en) * | 2009-10-19 | 2013-09-19 | Vatrix Medical Inc. | Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections |
US9889279B2 (en) * | 2009-10-19 | 2018-02-13 | Nectero Medical, Inc. | Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections |
CN105536123A (zh) * | 2016-02-18 | 2016-05-04 | 仇汉诚 | 一种球囊导管 |
Also Published As
Publication number | Publication date |
---|---|
EP1404404A1 (fr) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4445125B2 (ja) | 分岐部における病変のための拡張及びステント配送用カテーテル | |
EP1101455B1 (fr) | Système de délivrance de stent muni d'un fil fixe de guidage | |
US9901715B2 (en) | Retractable sheath devices, systems, and methods | |
US5843027A (en) | Balloon sheath | |
JP2918502B2 (ja) | ステント挿入用バルーンカテーテル | |
US7011673B2 (en) | Stent delivery system with a fixed guide wire | |
US7226472B2 (en) | Catheter balloon with advantageous cone design | |
US8323307B2 (en) | Balloon catheter with dilating elements | |
JP2999165B2 (ja) | ステント供給装置 | |
JPH09512458A (ja) | 体内人工器官及びステントの配置 | |
EP3082661B1 (fr) | Cathéters à ballonnet et système | |
JP5259070B2 (ja) | 操縦可能型ガイドワイヤを用いたステント配送システム | |
JP2002539902A (ja) | バルーンカテーテルおよびステント配備カテーテルシステム | |
US20060041269A1 (en) | Vessel isolation device | |
WO2007136637A1 (fr) | Cathéter à double ballonnet et procédé de déploiement de celui-ci | |
JP2007500040A (ja) | 分岐ステント搬送システム | |
CN113260405A (zh) | 双球囊导管以及使用方法 | |
WO2022264083A1 (fr) | Dispositif médical qui comprend un module de ballonnet | |
US20020065487A1 (en) | Method and device for use in micro-invasive surgical procedures, and guide catheter and valve unit for a device for use in micro-invasive surgical procedures | |
WO2003000332A1 (fr) | Catheter a ballonnet | |
US8309007B2 (en) | Folding apparatus and methods for bifurcation post-dilatation balloon | |
US20220387044A1 (en) | Catheter assembly including expandable perforation treatment device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002740750 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002740750 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002740750 Country of ref document: EP |